The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer

A. Tutt; M. Robson; J. E. Garber; S. M. Domchek; M. W. Audeh; J. N. Weitzel; M. Friedlander; B. Arun; N. Loman; R. K. Schmutzler; A. Wardley; G. Mitchell; H. Earl; M. Wickens; J. Carmichael; Cornelia Liedtke

doi:10.1159/000322170

The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer

A. Tutt, M. Robson, J. E. Garber, S. M. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, B. Arun, N. Loman, R. K. Schmutzler, A. Wardley, G. Mitchell, H. Earl, M. Wickens, J. Carmichael, Cornelia Liedtke

Breast Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	364-365
Number of pages	2
Journal	Breast Care
Volume	5
Issue number	5
DOIs	https://doi.org/10.1159/000322170
State	Published - Oct 2010

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1159/000322170

Cite this

Tutt, A., Robson, M., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R. K., Wardley, A., Mitchell, G., Earl, H., Wickens, M., Carmichael, J., & Liedtke, C. (2010). The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer. Breast Care, 5(5), 364-365. https://doi.org/10.1159/000322170

Tutt, A, Robson, M, Garber, JE, Domchek, SM, Audeh, MW, Weitzel, JN, Friedlander, M, Arun, B, Loman, N, Schmutzler, RK, Wardley, A, Mitchell, G, Earl, H, Wickens, M, Carmichael, J & Liedtke, C 2010, 'The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer', Breast Care, vol. 5, no. 5, pp. 364-365. https://doi.org/10.1159/000322170

@article{f2b0b0d1f35f400d8f400f6c713faac9,

title = "The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer",

author = "A. Tutt and M. Robson and Garber, {J. E.} and Domchek, {S. M.} and Audeh, {M. W.} and Weitzel, {J. N.} and M. Friedlander and B. Arun and N. Loman and Schmutzler, {R. K.} and A. Wardley and G. Mitchell and H. Earl and M. Wickens and J. Carmichael and Cornelia Liedtke",

year = "2010",

month = oct,

doi = "10.1159/000322170",

language = "English (US)",

volume = "5",

pages = "364--365",

journal = "Breast Care",

issn = "1661-3791",

publisher = "S. Karger AG",

number = "5",

}

TY - JOUR

T1 - The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer

AU - Tutt, A.

AU - Robson, M.

AU - Garber, J. E.

AU - Domchek, S. M.

AU - Audeh, M. W.

AU - Weitzel, J. N.

AU - Friedlander, M.

AU - Arun, B.

AU - Loman, N.

AU - Schmutzler, R. K.

AU - Wardley, A.

AU - Mitchell, G.

AU - Earl, H.

AU - Wickens, M.

AU - Carmichael, J.

AU - Liedtke, Cornelia

PY - 2010/10

Y1 - 2010/10

UR - http://www.scopus.com/inward/record.url?scp=78049394967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049394967&partnerID=8YFLogxK

U2 - 10.1159/000322170

DO - 10.1159/000322170

M3 - Comment/debate

AN - SCOPUS:78049394967

SN - 1661-3791

VL - 5

SP - 364

EP - 365

JO - Breast Care

JF - Breast Care

IS - 5

ER -

The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this